4//SEC Filing
Eliades George Christopher 4
Accession 0001209191-21-025490
CIK 0001720725other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 7:32 PM ET
Size
7.4 KB
Accession
0001209191-21-025490
Insider Transaction Report
Form 4
Eliades George Christopher
Director
Transactions
- Award
Common Stock
2021-04-02+19,935→ 19,935 total - Award
Common Stock
2021-04-02+1,650→ 21,585 total
Footnotes (3)
- [F1]This security represents restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]1/3 of the RSUs will vest in three equal annual installments, with 1/3 vesting on the one (1) year anniversary of April 2, 2021, and one-third (1/3) of the RSUs vesting annually thereafter on April 2, subject to the Reporting Person continuing to be a service provider pursuant to the terms of the Issuer's 2019 Equity Incentive Plan through each such date.
- [F3]1/3 of the RSUs will vest monthly on the same day of the month beginning on April 8, 2021 until the Company's Annual Meeting of Stockholders to be held in 2021; provided, however, if all of such RSUs are not fully vested at the Company's next Annual Meeting, any such remaining RSUs will vest on the date of the Company's next Annual Meeting, in each case, subject to the Reporting Person continuing to be a service provider pursuant to the terms of the Issuer's 2019 Equity Incentive Plan through each such date.
Documents
Issuer
Oyster Point Pharma, Inc.
CIK 0001720725
Entity typeother
Related Parties
1- filerCIK 0001855251
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 7:32 PM ET
- Size
- 7.4 KB